Skip to main content
. 2013 Sep 13;5(1):16. doi: 10.1186/1868-7083-5-16

Table 1.

RT-PCR analysis for selected genes in chromosomal regions of deletion or amplification/duplication in primary RCC tumours and associated normal tissue

Deletions
Chromosome
Potential tumour specifically inactivated genes
 
Tum Exp. Lost/Tum. Exp. Down-regulated/Tum. Exp. Normal or Up-regulated (Percentage of lost/down-regulated)
 
Chromosome 1
CHD5
TNFRSF1B
KIF17
UQCRH
GPX7
0/1/14 (6.7%)
0/0/15 (0.0%)
0/0/15 (0.0%)
0/0/15 (0.0%)
0/0/15 (0.0%)
TTC22
PDE4DIP
RGS7
TRIM58
 
1/1/13 (13.3%)
0/0/15 (0.0%)
3/4/8 (46.7%)
0/2/13 (13.1%)
 
Chromosome 6
GCM2
HIST1H3G
HIST1H4H
 
 
8/0/2 (80.0%)
0/0/15 (0.0%)
0/0/15 (0.0%)
 
 
Chromosome 8p
GATA4
NEFM
 
 
 
1/0/8 (11.1%)
1/2/12 (20.0%)
 
 
 
Chromosome 14q
EFS
PTGDR
C14orf39
FLRT2
 
0/1/14 (6.7%)
0/1/14 (6.7%)
1/0/8 (11.1%)
0/1/14 (6.7%)
 
Amplifications
Chromosome
Potential tumour specifically inactivated genes
 
 
(Percentage of tumours in which gene expression is lost or down-regulated in brackets)
 
Chromosome 1
TWIST1
HOXA11
AEBP1
KLF14
 
 
1/0/13 (7.1%)1
0/2/13 (13.3%)
3/0/12 (20.0%)
0/2/13 (13.3%)
 
Chromosome 8p
SOX17
CA3
ANGPT1
TMEM74
 
  0/2/13 (13.3%) 0/3/12 (20.0%) 0/0/15 (0.0%) 4/3/8 (46.7%)  

1Key= Tumour Expression Lost/Tumour Expression Down-regulated/Tumour Expression Normal or Up-regulated (Percentage of lost/down-regulated).

Genes in bold type (GCM2, RGS7 and NEFM) demonstrated complete loss or downregulation of expression in at least 20% of RCC tumours and were located in regions of deletion.